Introduction: Antibiotic-loaded bone cements of poly(methyl methacrylate) are considered as very useful biomaterials for the management of corporal deep osseous infections. However, the high prevalence of resistant germs and polymicrobial infections makes it necessary to search for new formulations of bone cements containing antibiotics for local antibacterial therapy. In this work, bone cements loaded with drugs with different mechanism of action were evaluated to determine its antibacterial effectiveness on Pseudomonas aeruginosa. Methodology: Poly(methyl methacrylate) cements loaded with 10 wt.% of Oleozon®, mixtures of Ciprofloxacin/Meropenem and Ciprofloxacin/Meropenem/Oleozon® were prepared. The in vitro drugs release in water was followed by UV-Vis spectroscopy, and their antibacterial activity against Pseudomonas aeruginosa was evaluated for 11 days using the microdilution method.
Introduction
Septic processes of joint prostheses, open bone fractures, non-unions of fractures and osteomyelitis illness are deep infections of the musculoskeletal system that are considered severe disorders due to the psychological and physical consequences for patients, as well as the complexity of their treatment [1] [2] [3] .
In recent years, periprosthetic joint infections (PJIs) have been reduced in many countries to 1-2 % [4, 5] or less [6] . However, the high incidence of pathologies or traumatic orthopedic lesions that conduces to total joint replacements is increasing around the world and therefore, also the number of patients with the possibility to develop PJIs [7] . Osteomyelitis (an inflammatory process of the entire bone with the bone destruction caused by an infecting organism [8] ) remains likewise as a severe worldwide problem, causing plenty of hospital admissions and requiring considerable expenses [9] . To treat it, the efforts are made by multidisciplinary specialists to diminish costs, co-morbidities and mortality in patients.
The management of bone infections is often characterized by the use of systemic antibiotic therapy, local drugs administration and surgical treatments. Surgical options of PJIs include [3] :  irrigation and cleaning with retention of the prosthesis (success rate 0%-89%) [10] ;  single-stage revision surgery (success rate > 80 %)
[11]  two-stage revision surgery (success rate 87 %) [12]  arthrodesis (success rate varying from 60 %-100 %)
[3]  amputation Bone cements of poly(methyl methacrylate) (PMMA) loaded with antibiotics represent the current gold standard for local antibiotic delivery in many of these surgical treatments. They can be used in the fixation of the primary joint prosthesis, fixation of the prosthesis in single-state or in the two-stage revision surgeries as well as temporary devices for local drug release in the form of PMMA-chain beads or PMMAjoint spacers.
As local drug carrier, the acrylic cements in some cases perform a prophylactic function because they incorporate low doses of the drug, but in others, they are designed to release high antibiotics concentrations directly to the affected tissues or to joint spaces [13] without severe risks of systemic toxicity [14] . They facilitate the formulation of custom-made drug carriers directly in the surgical room and allow surgeons choose the antibiotic and its dose according to the virulence, antibiotic sensitivity profile of the causative germs and the medical condition of patients [15, 16] .
Among the most common pathogens reported as responsible for Osteomyelitis in humans are recurrently the Staphylococcus species, followed by Enterobacteriaceae and Pseudomonas species [17] , while in the Osteomyelitis associated with implants the Staphylococcus epidermidis is present more than 90 % of the time [18] . For PJIs, the spectrum of causative bacteria is broad, including: Coagulase-negative staphylococci (30-43 %); Staphylococcus aureus (12-23 %); Streptococci (9-10 %); Enterococci (3-7 %); Gram-negative bacilli (3-6 %); anaerobes (2-4 %); multiple pathogens (polymicrobial) (10-12 %) or unknown microbes (10-11 %) [19] .
The great diversity of germs together with the recent growth of antibiotic-resistant strains, the formation of bacterial biofilm on the surface of the materials, or the presence of polymicrobial infections complicate in great grade the management of the deep musculoskeletal infections, and for these reasons, they still represent a major challenge [20, 21] .
The strategies to face up this new and complex context include the use of novel antimicrobial agents with high bone penetration for oral and parenteral antibiotic treatment such as: linezolid, daptomycin and tigecycline [22] ; the exploration of the use of nonclassical antibiotics to load acrylic bone cement such as: amphotericin B [23] , grepafloxacin [24] , teicoplanin [25] or meropenem [26] ; the use of combined drugs in the cements in order to increase the antimicrobial spectrum and the potential antibiotics concentrations in tissues as gentamicin/linezolid [27] , vancomycin/linezolid [27] , gentamicin/teicoplanin [28] , vancomycin/daptomycin [29] , vancomycin/cefazolin [30] , ciprofloxacin/ceftazidime [31] , ciprofloxacin/meropenem [31] or the development of biodegradable implants for local antibiotics release in Osteomyelitis therapy [32] .
Nowadays, the best evidence for an adequate antibiotic selection is available mainly for staphylococci species while for other bacteria such as streptococci, enterococci or Gram-negatives, the evidence for antibiotic selection is less clear [33] . Given the great problem that represent the emergence of resistant Gram-negative organisms as in the case of Pseudomonas aeruginosa, nowadays, it is vital to test new drugs with novel mechanisms of antibacterial action or the proposal of new combination of drugs eluting from acrylic bone cements in special with different action's mechanism on bacteria to broad the antibacterial spectrum and counteracting further resistance mechanisms.
Ozonated sunflower oils have been effective in the treatment of viral, bacterial, fungal and protozoal infections [34] [35] [36] . In vitro tests of ozonized vegetable oils have shown their activity against a large number of microorganism species. The values of Minimum Inhibitory Concentration (MIC) vary depending on the type of microorganisms and the physical-chemical characteristics of the oils, obtaining values between 0.1 mg mL -1 to 17.5 mg mL -1 . Oleozon® a Cuban drug obtained from the reaction of ozone with sunflower seed oil has antimicrobial activity demonstrated in different studies, its biological activity is attributed mainly to peroxidic species, including α-hydroxyhydroperoxides, peracids, α-acyloxy-hydroperoxides and ozonides [37] . The hypothesis established is that damage to the cell membrane occurs due to the oxidation produced by peroxides and alterations in enzymatic complexes essential for the microbial cell [38] .
In this work, was evaluated the effect of acrylic cements loaded with combined drugs of different action's mechanism such as ozonized sunflower oil and ozonized oil/Ciprofloxacin/Meropenem on Pseudomonas aeruginosa cultures as an example of common Gram-negative germ in PJIs, in Osteomyelitis or in open bone fractures. The possibility to include Oleozon® in the acrylic cement formulations is likely to increase the option of treatments to be considered by surgeons and represents the first report of this alternative. Moreover bearing in mind that in developing countries medical products that are marketed internationally are not always available in their hospitals, and facing the urgent clinical necessity to provide an efficient treatment in severe septic processes associated with bone injuries, National Health Systems have to develop domestic formulations for such cases.
Methodology

Acrylic bone cements formulations
Acrylic cements formulations were prepared using conventional components of bone cements and high antibiotic dose (an equivalent of 4g of antibiotic per 40 g of cement) as is recommended for acrylic cements intended for antibacterial therapy. Table 1 shows the composition of the acrylic bone cements tested. Cement samples (unloaded and loaded with antibiotics) were hand mixed at room temperature and cured in spherical molds of silicon (0.6 Ø cm) for about 24 hours prior to testing.
In vitro tests
For the in vitro antimicrobial tests, the spherical cement probes were immersed in 2.5 mL of doubledistilled water at 37 ± 0.5 °C, and at 1, 3, 5, 7, 9 and 11 days after the initial immersion, the water with the drug released (extract) was replaced with 2.5 mL of fresh double-distilled water. Half of the extract was used for the quantification of the antibiotic released, and the other half was used for the in vitro antimicrobial tests. The tests were carried out in triplicate for each cement formulation.
Antibiotic release assay Drug release was followed by UV-Vis spectroscopy. The solution absorbance's measurements were made using a spectrophotometer Rayleigh UV-2601 (Beijing Rayleigh Analytical Instrument Corp., Beijing, China), at wavelengths of 228, 272 and 297 nm in correspondence with the UV-Vis maximums of absorption for Oleozon®, Ciprofloxacin and Meropenem respectively. The antibiotic concentration was calculated according to the Beer-Lambert's law using a calibration curve for the CementOleozon®(CO) extracts. For the extracts from the cements with a combination of drugs: Ciprofloxacin/Meropenem (CM) or Ciprofloxacin/Meropenem/Oleozon® (CMO), first was determined the extinction coefficient (ε) of the antibiotics at their respectively absorption maximums using standard solutions. Then, to take into account the contribution of each species to the global absorbance at each wavelength, an appropriate set of equations was used to calculate the concentration of each species in the extract. The percentages of antibiotic released were calculated with respect to the total amount incorporated in each spherical probe.
Antimicrobial in vitro assay
The broth microdilution method according to CLSI-M100-S24 (2014) was followed to evaluate the antimicrobial effectiveness of each cement formulation [39] .
Isolates of the control strain Pseudomonas aeruginosa (ATCC 27853) were cultured during 18-20 hours at 37 °C in tryptone soy agar (Merck, Darmstadt, Germany) as the first stage. Afterward, the inoculum preparation was carried out by re-suspension of 3-5 bacterial colonies in Mueller Hinton broth (Merck, Germany), followed by incubation with shaking for 3-5 hours at 35 °C until reaching a turbidity equal to 0.5 McFarland determined with the assistance of the DIRAMIC-10 equipment (CNIC, Havana, Cuba). Serial dilutions were made until obtaining a concentration of microorganisms of 5×10 4 CFU mL -1 . Later, in 96-well plates (BRAND GMBH Plates, Wertheim, Germany), 100 μL of the microorganism was inoculated aseptically and 100 μL of the extract of each cement formulation was added. Readings at a wavelength of 405 nm were performed on micro-ELISA equipment (TECNOSUMA®, Havana, Cuba) at different intervals during the first 24 hours to visualize the kinetics of death of the microorganisms in contact with cement extracts in comparison with curves of spontaneous growth of the Pseudomonas aeruginosa strain. During the experiments, the plates were maintained at 37 °C for an adequate incubation of the strain. All the tests were performed in triplicate.
Results
In vitro antibiotics release
In this work, the kinetics of drug release from acrylic bone cements was determined in vitro. The drug (Oleozon®) was used alone and in combination with Ciprofloxacin/Meropenem. Figure 1 shows the cumulative release of Oleozon® from Cement-O, of Ciprofloxacin or Meropenem from Cement-CM and the three antibacterial drugs from Cement-CMO.
All cements showed an initial rapid release of the antibiotic, and then the elution rate decreased to maintain a pattern of sustained drug release over time. This biphasic profile is attributed to the rapid dissolution of the antibiotic on the surface of the cement and then to the drug dissolution/diffusion through cracks, gaps or elution paths that allow the water to penetrate the PMMA matrix and reach and dissolve the antibiotic [40] .
Because the oily nature of the Oleozon® (hydrophobic drug), this drug was released at a lower rate and in smaller amount compared to Ciprofloxacin or Meropenem drugs ( Figure 1a and Table 2 ). Figure 1b (Cement-CM) shows that initially, the release of Meropenem is faster than that of Ciprofloxacin; from day 7 to 9, the amounts of drug released were statistically similar and by day 11, the quantity of Ciprofloxacin liberated was statistically higher than that of Meropenem. However, for the Cement-CMO sample, the differences between the amounts of drug released (Ciprofloxacin or Meropenem) were not statistically different during the entire in vitro assay (11 days), Figure 1c . The presence of Oleozon® led to a modification of the release pattern of the Ciprofloxacin and Meropenem, reducing the elution rate of both drugs. The elution rate of Ciprofloxacin was the one that showed the greatest decrease. The cumulative release of the Ciprofloxacin and Meropenem from Cement-CMO samples decreased in comparison with the Cement-CM samples, 13 % for Ciprofloxacin and 5.6 % for Meropenem (Table 2) . Conversely, the amount of Oleozon® released increased slightly by the presence of the two other hydrophilic drugs in Cement-CMO almost 3 %. The dispersion of the cumulative release data of Ciprofloxacin and Meropenem indicates that the release process was made more complex by the presence of Oleozon® in the system (a hydrophobic drug) and therefore, higher standard deviations were obtained in the accumulated concentrations of these drugs.
In vitro antibacterial effectiveness
In this work, the antibacterial activity of the new formulations of antibiotic-loaded bone cements (ALBC) was determined against one of the bacilli that causes the highest number of intrahospitalary infections and the most complicated of the nosocomial infections to treat: Pseudomonas aeruginosa [41] . Figure 2 summarizes the antibacterial activity of the extracts from the Cement-CO, Cement-CM and Cement-CMO taken at 1, 5 and 11 days as representative of the antibacterial test. It is observed that in Figures 2a-c the extracts of the acrylic bone cement without any drug present immediately after inoculation of the plates a short period where D/Do (optical density ratio, Dt/Dinitial) is almost constant. This effect is a consequence that the bacteria first synthesize the enzymes that allow them to multiply later, so the cells may grow in size but not in numbers. Then, the number of bacteria increases with time even at 24 hours of the assay, indicating that bacterial growth is not limited by the depletion of essential nutrients and/or the formation of an inhibitory product.
It is possible to appreciate from Figure 2a , that the extracts for all ALBCs have significant antibacterial effect during the first day. However, the extracts from the Cement-CO, after the first 20 hrs started to lose effectiveness. The extracts from Cement-CO of day 1 released to the surrounding medium 88.4 ± 6.3 µg of Oleozon® and this amount inhibited around 77 % the growth of the strain. Extracts from days 5 and 11 caused less inhibition, Figures 2b and 2c . The statistical analyses indicated no differences in the D/Do values of the Cement-CO extracts taken at the day 3, 5, 7, 9 and 11 day of the assay after 24 hours of being in contact with the strain. In all cases, the inhibitory effect on the bacterial growth was about 50 %.
The extracts of the Cement-CM and Cement-CMO at 1, 5 and 11 days completely inhibited the growth of the bacilli which indicate that probably the antibacterial effectiveness will be maintained for more time, Figure  2a -c.
Discussion
Local antibiotic therapy using acrylic bone cements as drug carrier is a common procedure for treatments of PJIs, Osteomyelitis or septic open bone fractures, therapy that have demonstrated excellent clinical results over the years. For a suitable antimicrobial performance, ALBCs must supply high drugs concentrations to tissues during the early postoperative period, levels above the Minimal Inhibitory Concentrations (MICs) of the causative organism(s). The simultaneous addition of two antibiotics or more into bone cement, in addition to increasing the antimicrobial spectrum, it usually results in a greater elution compared to bone cement loaded with one antibiotic [16] , these effect is named Passive Opportunism [42] . The release of the more soluble drug open cavities and cracks in the cement matrix facilitating the elution of the remaining antibiotic from layers' nearest to surface. This effect has been reported when using specific antibiotics pairs such as Ciprofloxacin/Meropenem [31] .
In this sudy, an effect of Passive Opportunism due to the presence of Oleozon® was not observed in the water-soluble drugs (Table 2) . However, this Passive Opportunism effect was found for the release of Oleozon® due to the presence of Ciprofloxacin and Meropenem, since these drugs upon dissolution increase the elution pathways of the drug occluded in the innermost layers of the matrix ( Figure 1a and Table  2 ).
Reports of experimental cements with only Meropenem in a concentration of 10% by weight show a good release behavior. For example, Samuel et al. [26] showed that Meropenem elutes in pharmacologically measurable concentrations from ALBC during a period of 3 to 27 days depending on the concentration of antibiotic used; on day 27 only the 2.18 % of the initial amount of the drug was released. However, the extracts retained their bioactivity against several types of microorganisms typical of infected arthroplasties for at least three weeks [26] .
The concentration of Meropenem extracts reported by Samuel et al. [26] at 24 hours using ALBC cylinders (1.6 cm length and 1.2 cm in diameter) loaded with 10 wt.% of Meropenem, and 30 mL of a saline solution reached 27.94 mg L -1 ; while in our work the concentration of Meropenem detected at 24 hours was around 751.6 mg L -1 for the Cement-CM and 369.0 mg L -1 in the Cement-CMO. Gálvez-López et al. [43] used ALBC beads (0.5 cm in diameter) loaded with 10 wt.% of Meropenem immersed in 1 mL of PBS at 37 °C, obtaining a concentration around 67 mg L -1 in the extract on the first 48 h. By comparing the amount of Meropenem liberated per unit of probe area, it was found that the ALBC tested by Samuel released 0.1 mg cm -2 at 24 h, the ALBC used by Gálvez-López liberated 0.085 mg cm -2 in the first 48 hrs. In this work, in the first 24 hours were released 1.66 mg cm -2 when using Cement-CM, and 0.82 mg cm -2 when using Cement-CMO. At day 6 Samuel et al. reported that the extract had 0.018 mg cm -2 of Meropenem, whereas at day 7, Gálvez-López et al. [43] reported 0.012 mg cm -2 in the extract. At day 7 in our test the Cement-CM released 0.098 mg cm -2 and the Cement-CMO 0.244 mg cm -2 . Therefore, in our study, the amount of drug released initially was higher, and higher amounts of the drug were released for a longer time than the values reported by Samuel et al. and Gálvez-López et al. According to the first national prospective surveillance study assessing antimicrobial activity of Meropenem against clinical isolates from French hospitals, the MIC50 and MIC90 determined by the agar dilution reference method were 0.5 mg L -1 and 4 mg L -1 respectively [44] , values that were overcomed several times for the Meropenem eluting concentrations from Cement-CM and Cement-CMO obtained in this work. The greater concentrations of Meropenem detected in this work were associated with the Passive Opportunism reported previously for the Ciprofloxacin/Meropenem couple drugs [31] .
The acrylic beads used in clinical are usually loaded with gentamicin are most often fabricated in chains of 30 beads that locally produce concentrations around 300 mg L -1 far above the MIC values for most microorganisms [45] .
Reports on the use of acrylic bone cements loaded with 10% by weight of Ciprofloxacin or with Oleozon® were not found in the literature. So, this work is an original proposal.
Antibacterial effectiveness on Pseudomonas aeruginosa of the cement formulations
The evaluation of the delivery capacity to the biological medium of a drug from medical devices for local antibiotic therapy (as cement beads or acrylic joint spacers) together with the evaluation of its antimicrobial effectiveness remains of great interest in current medicine.
Pseudomonas aeruginosa is strain that can propagate on medical devices, hospital environment and even in disinfectants [46] . It is considered as an opportunism Gram-negative microorganism that commonly appears in concomitancy with other germs in the PJIs or in Osteomyelitis disease associated with injection drug use, catheter-related infections or after urinary tract instrumentation [32] . At present time, Pseudomonas aeruginosa has grown in importance as a causative agent of deep infections on the rising number of high-energy traumas associated with open fractures, as a consequence of traffic accidents and war injuries [22, 32, 47] . It is argued that Pseudomonas aeruginosa is one of the most difficult germ to eradicate, once established within the joint [48, 49] because of its resistance to a variety of antimicrobial agents [50] and to its ability to acquired further resistance, even in antipseudomonal chemotherapy [41] , extreme treatments are required [46] . The presence of this virulent pathogen in PJIs may require multiple revisions if its eradication is not achieved [51] .
It is known that the mechanism of action of the antibiotic on bacteria are quite diverse. Most current bactericidal antimicrobials inhibit DNA synthesis, RNA synthesis, cell wall synthesis, or protein synthesis [52] . Antibiotic-mediated cell death is a complex process that begins with the physical interaction between a drug molecule and its bacterial-specific target and involves alterations to the affected bacterium at the biochemical, molecular and ultrastructural levels [53] .
Combinatorial antibiotic treatments can have diverse effects on bacterial survival. Antibiotics can be more effective when combined, displaying either an additive effect (effect equal to the sum of treatments) or a synergistic effect (effect greater than the sum of treatments). The combination of antibiotics can also be antagonistic [53] .
In this work, three types of drugs were used alone or in combination as part of an ALBC formulation. Ciprofloxacin belonging to the family of the fluoroquinolones contributes to the inhibition of nucleic acid synthesis because it affects DNA replication [53] , Meropenem a β-lactam antibiotic interferes with specific steps in homeostatic cell wall biosynthesis [53] whereas Oleozon® affects the cell membrane perhaps as a consequence of the peroxidation and modifications in enzymatic complexes essential for bacteria.
Results of this work indicate a better antibacterial effect by the combined used of two or the three drugs in ALBC against Gram-negative bacilli. However, the period of the antibacterial effectiveness tested was too short to prove differences between Cement-CM and Cement-CMO formulations.
Since the groups of bacteria most sensitive to Oleozon® are mycobacteria and gram-positive cocci, it is expected that the incorporation of this drug to bone cement can contribute to eradicating them in the PJI or in Osteomyelitis. In addition, taking into account the wide availability of sunflower oils, Oleozon® becomes a competitive antimicrobial agent that, together with the proven synergic effect that is induced when the Ciprofloxacin/Meropenem combination is used [31] , makes these new formulations of cement be a valid ALBCs alternative to be considered by surgeons.
Conclusion
Bone cements loaded with antibiotics were prepared with Oleozon®, mixtures of Ciprofloxacin/Meropenem and of Ciprofloxacin/Meropenem/Oleozon®. All the drugs elute from the cement probes as active ingredients against Pseudomonas aeruginosa cultures, and at the end of the trial period, some of the drugs remained inside the matrices, indicating that they can be used for a longer time in treatments. The cement extracts with Oleozon® demonstrated an inhibitory effect on the growth of the strain during the whole trial period, however, at the end of the test (11 days), only a decrease of about 50 % of the bacterial growth was obtained. The extracts from cements with mixtures of Ciprofloxacin/Meropenem and Ciprofloxacin/Meropenem/Oleozon® showed complete inhibition of the growth of the microorganisms, even at 11 days, time that the test lasted. The incorporation of Oleozon® to the acrylic cement alone or in combination with other drugs (as Ciprofloxacin/Meropenem) may contribute to eliminating mycobacteria and Gram-positive cocci, the most germs in the PJIs or in Osteomyelitis, in addition to Gram-negative germs as Pseudomonas aeruginosa.
In future work, in vitro studies will be carried out with other types of strains present in septic musculoskeletal processes to confirm the antibacterial effectiveness of the proposed acrylic cement formulations. In vivo studies will also be carried out to verify if cement formulations with Oleozon® are effective for the control of sepsis
